Announces that it has completed the TSX delisting review and confirms that the Company satisfies the ...
Successful completion of TSX listing reviewExpansion of adult-use portfolio into key fifth province5 provinces now selling Aleafia’s adult-use products TORONTO, Nov. 28, 2022 (GLOBE NEWSWIRE) -- Further to its previous announcements, Aleafia Health Inc. (TSX: AH, OTCQB: ALEAF) (“Aleafia Health” or the “Company”) is pleased to announce that it has completed the TSX delisting review and confirms that the Company satisfies the Toronto Stock Exchange’s requirements for continued listing. Aleafia Hea
Adjusted EBITDA1 profitability achieved in Q2 FY2023, ahead of plan21% increase in total revenue year over year to $14.5 23% increase in branded cannabis net revenue2 year over year to $9.4 million #3 ranking in total retail sales pull through growth among 20 top Canadian LPs3#2 milled and #4 pre-roll market share ranking in key Ontario market for Divvy4Record quarter in international net revenue516% increase in medical net revenue6 over the prior year 35% gross profit margin versus -41% in the